Skip to main content
Atrás
Watch Compare

LENZ Therapeutics, Inc.

Calidad de datos: 100%
LENZ
Nasdaq Manufacturing Chemicals
$9.26
▼ $0.20 (-2.06%)
Cap. Mercado: 290.18 M
Precio
$9.26
Cap. Mercado
290.18 M
Rango del Día
$9.20 — $9.56
Rango de 52 Semanas
$8.25 — $50.40
Volumen
300,487
Apertura $9.28
Promedio 50D / 200D
$12.85
27.98% below
Promedio 50D / 200D
$26.72
65.36% below

Quick Summary

Puntos Clave

Negative free cash flow of -70.00 M
Capital efficient — spends only 4.33% of revenue on capex

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-41.03%
Above sector avg (-51.02%)
ROIC-35.88%
Net Margin-430.25%
Op. Margin-477.46%

Seguridad

Debt / Equity
N/A
Current Ratio12.69
Interest CoverageN/A

Valoración

PE (TTM)
-3.53
Below sector avg (-1.98)
P/B Ratio1.50
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (44 pares)
Métrica Acción Mediana del Sector
P/E -3.5 -2.0
P/B 1.5 5.1
ROE % -41.0 -51.0
Net Margin % -430.3 -150.2
Rev Growth 5Y % — 9.3
D/E — 0.3

ETFs Holding This Stock

PILL logo PILL Direxion Daily Pharmaceutical & Medical Bull 3X ETF
0.56% weight
AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0.06% weight
WSGE logo WSGE Warren Street Global Equity ETF
0.03% weight
ISCB logo ISCB iShares Morningstar Small-Cap ETF
0.01% weight
IWV logo IWV iShares Russell 3000 ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 19.09 M Net Income (TTM) -82.13 M
ROE -41.03% ROA -38.37%
Gross Margin N/A Operating Margin -477.46%
Net Margin -430.25% Free Cash Flow (TTM) -70.00 M
ROIC -35.88% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 12.69
Interest Coverage N/A Asset Turnover 0.09
Working Capital 190.68 M Tangible Book Value 193.93 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -3.53 Forward P/E N/A
P/B Ratio 1.50 P/S Ratio 15.20
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -24.12%
Market Cap 290.18 M Enterprise Value 264.79 M
Per Share
EPS (Diluted TTM) -2.85 Revenue / Share 0.61
FCF / Share -2.23 OCF / Share -2.21
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 4.33% FCF Conversion 85.23%
SBC-Adj. FCF -81.06 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 19.09 M — — — —
Net Income -82.13 M -49.77 M -124.65 M -101.05 M -70.76 M
EPS (Diluted) -2.85 -2.34 -2.19 -1.84 —
Gross Profit — — — — —
Operating Income -91.14 M -58.61 M -135.19 M -105.64 M -60.44 M
EBITDA — — — — —
R&D Expenses 18.67 M 29.80 M 32.14 M 72.79 M 37.93 M
SG&A Expenses 91.14 M 28.81 M — — —
D&A 287,000.0 58,000.0 2.41 M 2.35 M 734,000.0
Interest Expense — — — — —
Income Tax 502,000.0 1,000.0 — 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 305.88 M 215.30 M 188.46 M 321.90 M 401.99 M
Total Liabilities 21.54 M 11.22 M 4.87 M 25.61 M 17.94 M
Shareholders' Equity 284.34 M 204.08 M 183.58 M 296.29 M 384.05 M
Total Debt — — — — —
Cash & Equivalents 25.18 M 20.16 M 184.26 M 47.73 M 376.98 M
Current Assets 301.41 M 211.92 M 188.02 M 275.37 M 381.74 M
Current Liabilities 21.19 M 10.41 M 4.80 M 13.04 M 12.14 M